Literature DB >> 21958867

Delta oscillations induced by ketamine increase energy levels in sleep-wake related brain regions.

M Dworak1, R W McCarley, T Kim, R Basheer.   

Abstract

Neuronal signaling consumes much of the brain energy, mainly through the restoration of the membrane potential (MP) by ATP-consuming ionic pumps. We have reported that, compared with waking, ATP levels increase during the initial hours of natural slow-wave sleep, a time with prominent electroencephalogram (EEG) delta oscillations (0.5-4.5 Hz). We have hypothesized that there is a delta oscillation-ATP increase coupling, since, during delta waves, neurons exhibit a prolonged hyperpolarizing phase followed by a very brief phase of action potentials. However, direct proof of this hypothesis is lacking, and rapid changes in EEG/neuronal activity preclude measurement in the naturally sleeping brain. Thus, to induce a uniform state with pure delta oscillations and one previously shown to be accompanied by a similar pattern of neuronal activity during delta waves as natural sleep, we used ketamine-xylazine treatment in rats. We here report that, with this treatment, the high-energy molecules ATP and ADP increased in frontal and cingulate cortices, basal forebrain, and hippocampus compared with spontaneous waking. Moreover, the degree of ATP increase positively and significantly correlated with the degree of EEG delta activity. Supporting the hypothesis of decreased ATP consumption during delta activity, the ATP-consuming Na+-K+-ATPase mRNA levels were significantly decreased, whereas the mRNAs for the ATP-producing cytochrome c oxidase (COX) subunits COX III and COX IVa were unchanged. Taken together, these data support the hypothesis of a cortical delta oscillation-dependent reduction in ATP consumption, thus providing the brain with increased ATP availability, and likely occurring because of reduced Na+-K+-ATPase-related energy consumption. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21958867      PMCID: PMC3576049          DOI: 10.1016/j.neuroscience.2011.09.027

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  62 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Quantitative autoradiographic localization of NMDA receptors in rat brain using [3H]CPP: comparison with [3H]TCP binding sites.

Authors:  M F Jarvis; D E Murphy; M Williams
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

3.  Energy-efficient action potentials in hippocampal mossy fibers.

Authors:  Henrik Alle; Arnd Roth; Jörg R P Geiger
Journal:  Science       Date:  2009-09-11       Impact factor: 47.728

4.  Sleep and brain energy levels: ATP changes during sleep.

Authors:  Markus Dworak; Robert W McCarley; Tae Kim; Anna V Kalinchuk; Radhika Basheer
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

5.  Mammalian TOR: a homeostatic ATP sensor.

Authors:  P B Dennis; A Jaeschke; M Saitoh; B Fowler; S C Kozma; G Thomas
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

6.  Changes in components of energy regulation in mouse cortex with increases in wakefulness.

Authors:  Elena V Nikonova; Nirinjini Naidoo; Lin Zhang; Micah Romer; Jacqueline R Cater; Matthew T Scharf; Raymond J Galante; Allan I Pack
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

Review 7.  General anesthesia, sleep, and coma.

Authors:  Emery N Brown; Ralph Lydic; Nicholas D Schiff
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

Review 8.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy.

Authors:  D Grahame Hardie
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

Review 9.  Adenosine and sleep-wake regulation.

Authors:  Radhika Basheer; Robert E Strecker; Mahesh M Thakkar; Robert W McCarley
Journal:  Prog Neurobiol       Date:  2004-08       Impact factor: 11.685

Review 10.  Sleep-wake mechanisms and basal forebrain circuitry.

Authors:  Laszlo Zaborszky; Alvaro Duque
Journal:  Front Biosci       Date:  2003-09-01
View more
  6 in total

1.  D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.

Authors:  B Kalyanasundar; Claudia I Perez; Alvaro Luna; Jessica Solorio; Mario G Moreno; David Elias; Sidney A Simon; Ranier Gutierrez
Journal:  J Neurophysiol       Date:  2015-05-13       Impact factor: 2.714

2.  Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.

Authors:  Dávid Nagy; Milan Stoiljkovic; Frank S Menniti; Mihály Hajós
Journal:  Neuropsychopharmacology       Date:  2015-09-25       Impact factor: 7.853

3.  Cellular registration without behavioral recall of olfactory sensory input under general anesthesia.

Authors:  Andrew R Samuelsson; Nicole R Brandon; Pei Tang; Yan Xu
Journal:  Anesthesiology       Date:  2014-04       Impact factor: 7.892

4.  A novel dynamic network imaging analysis method reveals aging-related fragmentation of cortical networks in mouse.

Authors:  Daniel A Llano; Chihua Ma; Umberto Di Fabrizio; Aynaz Taheri; Kevin A Stebbings; Georgiy Yudintsev; Gang Xiao; Robert V Kenyon; Tanya Y Berger-Wolf
Journal:  Netw Neurosci       Date:  2021-06-21

5.  Computational Classification Approach to Profile Neuron Subtypes from Brain Activity Mapping Data.

Authors:  Meng Li; Fang Zhao; Jason Lee; Dong Wang; Hui Kuang; Joe Z Tsien
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

6.  EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis.

Authors:  Santiago Castro-Zaballa; Matías Lorenzo Cavelli; Joaquin Gonzalez; Antonio Egidio Nardi; Sergio Machado; Cecilia Scorza; Pablo Torterolo
Journal:  Front Psychiatry       Date:  2019-01-17       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.